| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,354 | 13,445 | 13,870 | 14,206 | | Cost of Revenue | 8,615 | 9,021 | 8,887 | 14,238 | | | Gross Profit | 4,739 | 4,424 | 4,983 | (32) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,152 | 6,801 | 8,154 | 15,380 | | Non Recurring | (2) | (179) | (2,667) |
-
| | Others |
-
|
-
|
-
| (125) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,411) | (2,198) | (504) | (15,287) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 94 | 674 | 147 | 230 | | Earnings Before Interest And Taxes | (1,441) | (1,524) | (357) | (15,057) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,441) | (1,524) | (357) | (15,057) | | Income Tax Expense | 124 |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,441) | (1,524) | (357) | (15,057) | | | Non-recurring Events | | Discontinued Operations | 642 | 1,273 |
-
| 3 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (799) | (251) | (357) | (15,054) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($799) | ($251) | ($357) | ($15,054) |
|
0.02% Nasdaq 0.00%
Income Statement
